polypid
report
third
quarter
financial
results
operational
highlights
november
petah
tikva
israel
globe
newswire
polypid
nasdaq
pypd
phase
biopharmaceutical
company
focused
developing
targeted
locally
administered
therapeutics
using
proprietary
plex
technology
today
announced
report
third
quarter
financial
results
operational
highlights
open
financial
markets
wednesday
november
company
host
conference
call
webcast
eastern
time
discuss
results
provide
update
business
operations
conference
call
webcast
information
date
wednesday
november
time
eastern
time
united
states
israel
international
conference
id
webcast
https
mmc
p
polypid
polypid
phase
biopharmaceutical
company
focused
developing
targeted
locally
administered
therapeutics
using
proprietary
plex
encapsulation
matrix
technology
polypid
product
candidates
designed
address
diseases
high
unmet
medical
needs
pairing
plex
drugs
deliver
directly
precise
sites
body
predetermined
release
rates
durations
ranging
several
days
several
months
polypid
lead
product
candidate
phase
clinical
trials
prevention
ssis
different
type
surgeries
including
abdominal
surgery
polypid
technology
products
based
inventions
noam
emanuel
founder
chief
scientific
officer
company
additional
company
information
visit
statements
press
release
contains
projections
statements
regarding
future
events
future
financial
performance
statements
present
historical
facts
conditions
contained
release
statements
within
meaning
private
securities
litigation
reform
act
section
securities
act
amended
section
securities
exchange
act
amended
statements
predictions
reflect
current
beliefs
expectations
respect
future
events
based
assumptions
subject
risk
uncertainties
subject
change
time
actual
events
results
may
differ
materially
contained
projections
statements
statements
release
made
pursuant
safe
harbor
provisions
contained
private
securities
litigation
reform
act
references
links
websites
provided
convenience
information
contained
websites
incorporated
reference
press
release
polypid
responsible
contents
websites
contacts
polypid
dikla
czaczkes
akselbrad
evp
cfo
tel
investors
bob
yedid
lifesci
advisors
